|
| 34973110 | Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment. | Arch Toxicol | 2022 |
| 35533086 | Identification and Strategies to Mitigate High Total Clearance of Benzylamine-Substituted Biphenyl Ring Systems. | Mol Pharm | 2022 |
| 34195728 | Diversity-orientated synthesis of macrocyclic heterocycles using a double S<sub>N</sub>Ar approach. | Org Biomol Chem | 2021 |
| 33683117 | Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy. | J Med Chem | 2021 |
| 33646774 | Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles". | J Med Chem | 2021 |
| 33495510 | Design and optimisation of dendrimer-conjugated Bcl-2/x<sub>L</sub> inhibitor, AZD0466, with improved therapeutic index for cancer therapy. | Commun Biol | 2021 |
| 34478292 | Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> Efficacy. | J Med Chem | 2021 |
| 32988967 | AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-x<sub>L</sub>, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia. | Clin Cancer Res | 2020 |
| 33119085 | A-loop interactions in Mer tyrosine kinase give rise to inhibitors with two-step mechanism and long residence time of binding. | Biochem J | 2020 |
| 31361481 | Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles. | J Med Chem | 2019 |
| 30335946 | Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6. | ACS Chem Biol | 2018 |
| 28714680 | Correction to Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors. | J Med Chem | 2017 |
| 28485934 | Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors. | J Med Chem | 2017 |
| 28374589 | Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy. | J Med Chem | 2017 |
| 29206860 | The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1. | PLoS One | 2017 |
| 27994749 | Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. | ACS Med Chem Lett | 2016 |
| 25050640 | Synthesis of 3-(hetero)aryl tetrahydropyrazolo[3,4-c]pyridines by Suzuki-Miyaura cross-coupling methodology. | J Org Chem | 2014 |
| 24967667 | Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists. | J Med Chem | 2014 |
| 23541044 | Experimental testing of quantum mechanical predictions of mutagenicity: aminopyrazoles. | Chem Res Toxicol | 2013 |
| 22608962 | Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. | Bioorg Med Chem Lett | 2012 |
| 22691057 | Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017). | J Med Chem | 2012 |
| 19854647 | Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo. | Bioorg Med Chem Lett | 2009 |
| 15715490 | 8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors. | J Med Chem | 2005 |
| 12636410 | Asymmetric synthesis of aziridine 2-phosphonates from enantiopure sulfinimines (N-sulfinyl imines). Synthesis of alpha-amino phosphonates. | J Org Chem | 2003 |
| 11843615 | 2H-Azirine 3-phosphonates: a new class of chiral iminodienophiles. Asymmetric synthesis of quaternary piperidine phosphonates. | Org Lett | 2002 |
| 12529988 | Prostate-specific antigen (PSA)-mediated proliferation, androgenic regulation and inhibitory effects of LY312340 in HOS-TE85 (TE85) human osteosarcoma cells. | Anticancer Res | 2002 |
| 11334560 | Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen. | J Med Chem | 2001 |
| 10825956 | Asymmetric synthesis of alpha-methylphosphophenylalanine derivatives using sulfinimine-derived enantiopure aziridine-2-phosphonates. | Org Lett | 1999 |
| 11674458 | Concise Asymmetric Synthesis of alpha-Amino Acid Derivatives from N-Sulfinylimino Esters. | J Org Chem | 1999 |